In neurodegenerative diseases such as Alzheimer’s disease (AD), aberrant splicing of susceptibility alleles in genes like PICALM, CLU, and PTK2B has been implicated in disease progression, further demonstrating the critical role of splicing regulation in age-related disorders (Raj et al., 2018). This evidence concerns the gene PICALM and Alzheimer disease.